clinical trial · NCT07521137
Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
Candidiasis, VulvovaginalOCF001 Intravaginal GelPlacebo Gel
brief summary
A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Evaluating the Safety, Tolerability, and Efficacy of OCF001 Intravaginal Gel in Women with Acute Vulvovaginal Candidiasis
started
Apr 20, 2026
primary completion
Dec 31, 2026
completion
Dec 31, 2026
last updated
Apr 14, 2026
official title
A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Evaluating the Safety, Tolerability, and Efficacy of OCF001 Intravaginal Gel in Women With Acute Vulvovaginal Candidiasis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol